Guizhou Sanli Pharmaceutical Co Ltd (603439) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Guizhou Sanli Pharmaceutical Co Ltd (603439) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.19 Million ≈ $4.86 Million USD) by net assets (CN¥1.55 Billion ≈ $226.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Guizhou Sanli Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Guizhou Sanli Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Guizhou Sanli Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603439 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Guizhou Sanli Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Sanli Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Calian Technologies Ltd TO:CGY	0.022x
Synergie SE PA:SDG	0.093x
Hubei Radio and Television Information Network Co Ltd SHE:000665	0.012x
Guangdong Wencan Die Casting Co Ltd SHG:603348	0.030x
Zhongyin Babi Food Co. Ltd. SHG:605338	0.102x
Guangdong Green Precision Components Co. Ltd. SHE:300968	-0.033x
Gladstone Investment Corporation NASDAQ:GAIN	-0.228x
Sinosteel Luonai Materials Technology Co. Ltd. A SHG:688119	N/A

Annual Cash Flow Conversion Efficiency for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Guizhou Sanli Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $233.34 Million	CN¥107.07 Million ≈ $15.67 Million	0.067x	-58.52%
2023-12-31	CN¥1.71 Billion ≈ $250.13 Million	CN¥276.70 Million ≈ $40.49 Million	0.162x	-31.66%
2022-12-31	CN¥1.24 Billion ≈ $181.19 Million	CN¥293.29 Million ≈ $42.92 Million	0.237x	+57.68%
2021-12-31	CN¥1.03 Billion ≈ $151.02 Million	CN¥155.04 Million ≈ $22.69 Million	0.150x	+133.21%
2020-12-31	CN¥981.88 Million ≈ $143.68 Million	CN¥63.25 Million ≈ $9.26 Million	0.064x	-63.92%
2019-12-31	CN¥651.09 Million ≈ $95.27 Million	CN¥116.24 Million ≈ $17.01 Million	0.179x	+22.74%
2018-12-31	CN¥518.02 Million ≈ $75.80 Million	CN¥75.35 Million ≈ $11.03 Million	0.145x	+19.81%
2017-12-31	CN¥473.36 Million ≈ $69.27 Million	CN¥57.47 Million ≈ $8.41 Million	0.121x	+48.93%
2016-12-31	CN¥430.59 Million ≈ $63.01 Million	CN¥35.10 Million ≈ $5.14 Million	0.082x	-46.96%
2015-12-31	CN¥216.53 Million ≈ $31.68 Million	CN¥33.28 Million ≈ $4.87 Million	0.154x	+2870.82%
2014-12-31	CN¥108.92 Million ≈ $15.94 Million	CN¥563.46K ≈ $82.45K	0.005x	-98.81%
2013-12-31	CN¥69.09 Million ≈ $10.11 Million	CN¥30.09 Million ≈ $4.40 Million	0.435x	--

About Guizhou Sanli Pharmaceutical Co Ltd

SHG:603439 China Drug Manufacturers - Specialty & Generic

Market Cap

$663.62 Million

CN¥4.54 Billion CNY

Market Cap Rank

#10811 Global

#2948 in China

Share Price

CN¥11.09

Change (1 day)

+2.69%

52-Week Range

CN¥9.68 - CN¥17.00

All Time High

CN¥41.67